Clinical Trials Directory

We are doing this study to find out the most preferred method among lung cancer patients for being connected to remote patient monitoring (RPM) devices. RPM devices are instruments that a patient can use to measure their own weight and vital signs. We want to find out if patients have an easier, more efficient time setting up these devices by using a virtual interface or with the assistance of a human agent.

We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).

We are doing this study to find out if an experimental drug called AGTC-501 (the study drug) can preserve and/or improve the vision of people who have X-linked retinitis pigmentosa (XLRP). We also want to know what dose of the drug has the most desirable effects.

We are doing this study to evaluate the accuracy and utility of two remote vital sign monitoring devices, called TempTraq and VitalTraq, when used by blood cancer patients receiving chimeric antigen receptor (CAR) T-cell and bispecific T-cell engager (BiTE) therapies. In the future, these remote vital sign monitoring devices may help with earlier detection and intervention of treatment side effects, including cytokine release syndrome (CRS) and infections.

We are doing this study is to test the effectiveness of a new virtual exercise training program created for older individuals who are living with prediabetes.

We are doing this study to find out if there is a difference in breath analysis between patients with and without rejection after lung transplantation.

We are doing this study is to see if we can predict carotid artery function using wearable technology (for example, a FitBit®).

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.